Noradrenaline enhances Na‐K ATPase subunit expression by HuR‐induced mRNA stabilization and their transportation to the cell surface through PLC and PKC mediated pathway: Implications with REMS‐loss associated disorders

Abstract

AbstractRapid eye movement sleep (REMS) maintains brain excitability at least by regulating Na‐K ATPase activity. Although REMS deprivation (REMSD)‐associated elevated noradrenaline (NA) increases Na‐K ATPase protein expression, its mRNA transcription did not increase. We hypothesized and confirmed both in vivo as well as in vitro that elevated mRNA stability explains the apparent puzzle. The mRNA stability was measured in control and REMSD rat brain with or without in vivo treatment with α1‐adrenoceptor (AR) antagonist, prazosin (PRZ). Upon REMSD, Na‐K ATPase α1‐, and α2‐mRNA stability increased significantly, which was prevented by PRZ. To decipher the molecular mechanism of action, we estimated NA‐induced Na‐K ATPase mRNA stability in Neuro‐2a cells under controlled conditions and by transcription blockage using Actinomycin D (Act‐D). NA increased Na‐K ATPase mRNA stability, which was prevented by PRZ and propranolol (PRP, β‐AR antagonist). The knockdown assay confirmed that the increased mRNA stabilization was induced by elevated cytoplasmic abundance of Human antigen R (HuR) and involving (Phospholipase C) PLC‐mediated activation of Protein Kinase C (PKC). Additionally, using cell‐impermeable Enz‐link sulfo NHS‐SS‐Biotin, we observed that NA increased Na‐K ATPase α1‐subunits on the Neuro‐2a cell surface. We conclude that REMSD‐associated elevated NA, acting on α1‐ and β‐AR, increases nucleocytoplasmic translocation of HuR and increases Na‐K ATPase mRNA stability, resulting in increased Na‐K ATPase protein expression. The latter then gets translocated to the neuronal membrane surface involving both PKC and (Protein Kinase A) PKA‐mediated pathways. These findings may be exploited for the amelioration of REMSD‐associated chronic disorders and symptoms.